Abstract
Urinary tract infection, one of the commonest bacterial diseases in children, carries a substantial risk of serious complications. Amongst them, renal scarring and recurrent infections seem to be the most important. In this review, we analyze the pathogenesis of urinary tract infection in order to identify those children who run the highest risk of unfavorable outcome. During infection, multiple bacterial and host factors interact with each other. Bacteria possess specific characteristics involved in the process of adhesion, invasion, survival and host damage during infection. Host factors also substantially participate in the pathogenesis of the disease. According to current knowledge, the specific host response appears to be the main factor predisposing for complications. However, prompt and adequate treatment of acute urinary tract infection remains the most important measure to prevent scarring. Dysfunctional holding and elimination of urine, on the other hand, mainly seem to influence the development of recurrent infection. Despite intensive research for many years, urinary tract infections are still a challenge for patients and health care professionals.
Keywords: UTI, E. coli, renal scarring, recurrent infections
Current Pediatric Reviews
Title: Urinary Tract Infection. Why Do Some Children Get Complications, While Others Dont?
Volume: 3 Issue: 1
Author(s): Milan Chromek and Annelie Brauner
Affiliation:
Keywords: UTI, E. coli, renal scarring, recurrent infections
Abstract: Urinary tract infection, one of the commonest bacterial diseases in children, carries a substantial risk of serious complications. Amongst them, renal scarring and recurrent infections seem to be the most important. In this review, we analyze the pathogenesis of urinary tract infection in order to identify those children who run the highest risk of unfavorable outcome. During infection, multiple bacterial and host factors interact with each other. Bacteria possess specific characteristics involved in the process of adhesion, invasion, survival and host damage during infection. Host factors also substantially participate in the pathogenesis of the disease. According to current knowledge, the specific host response appears to be the main factor predisposing for complications. However, prompt and adequate treatment of acute urinary tract infection remains the most important measure to prevent scarring. Dysfunctional holding and elimination of urine, on the other hand, mainly seem to influence the development of recurrent infection. Despite intensive research for many years, urinary tract infections are still a challenge for patients and health care professionals.
Export Options
About this article
Cite this article as:
Chromek Milan and Brauner Annelie, Urinary Tract Infection. Why Do Some Children Get Complications, While Others Dont?, Current Pediatric Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/157339607779941705
DOI https://dx.doi.org/10.2174/157339607779941705 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Inflammation & Allergy - Drug Targets (Discontinued) Advances and Challenges in Drug Design of PPARδ Ligands
Current Drug Targets The Pathobiology of Osteoarthritis and the Rationale for Using the Chondroitin Sulfate for its Treatment
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Glucose Metabolism and Antidepressant Medication
Current Pharmaceutical Design Feasibility Study Evaluating Pentravan® for the Intravaginal Administration of Active Pharmaceutical Ingredients to Reduce Pelvic Pain Related to Endometriosis
Drug Delivery Letters Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes
Current Stem Cell Research & Therapy Protective Role of Melatonin in Liver Damage
Current Pharmaceutical Design Gene Therapy Strategies for Glaucomatous Neurodegeneration
Current Gene Therapy ImmunemiR - A Database of Prioritized Immune miRNA Disease Associations and its Interactome
MicroRNA Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1
Current Cancer Therapy Reviews Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Curcumin Prevents Brain Damage and Cognitive Dysfunction During Ischemic-reperfusion Through the Regulation of miR-7-5p
Current Neurovascular Research T Cell Cytokine Production in Childhood Asthma
Current Respiratory Medicine Reviews What Characterizes Endothelial Dysfunction in Preeclampsia? -The Action of NO and the Production of Prostacyclin is Reduced, While EDHF is Preserved in Omental Resistance Arteries in Preeclamptic Women
Current Women`s Health Reviews Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields
Current Pediatric Reviews Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
CNS & Neurological Disorders - Drug Targets Comparative Study on Clinical Characteristics of COVID-19 Patients with or without Digestive Symptoms in Razi Hospital, Ahvaz, Khuzestan
Endocrine, Metabolic & Immune Disorders - Drug Targets